Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Pulmonary Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pulmonary Drugsmarket, defines the market attractiveness level of Pulmonary Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pulmonary Drugs industry, describes the types of Pulmonary Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pulmonary Drugs market and the development prospects and opportunities of Pulmonary Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pulmonary Drugs market in Chapter 13.
By Player:
Cheisi Farmaceutici SpA
Meda Pharmaceuticals
Mallinckrodt Pharmaceuticals Plc
AstraZeneca Plc
Merck Sharp & Dohme Limited
Sanofi SA
Zambon Company SpA
GlaxoSmithKline Plc
Alaxia SAS
Circassia Pharmaceuticals Plc
By Type:
Inhaled Corticosteroids
Long Acting Beta-2 Agonists
Antihistamines
Vasodilators
Others
By End-User:
Others
Others
Others
Others
Others
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pulmonary Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pulmonary Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pulmonary Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pulmonary Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pulmonary Drugs Market Analysis and Outlook to 2022
-
7.1 Global Pulmonary Drugs Consumption (2017-2022)
-
7.2 United States Pulmonary Drugs Consumption (2017-2022)
-
7.3 Europe Pulmonary Drugs Consumption (2017-2022)
-
7.4 China Pulmonary Drugs Consumption (2017-2022)
-
7.5 Japan Pulmonary Drugs Consumption (2017-2022)
-
7.6 India Pulmonary Drugs Consumption (2017-2022)
-
7.7 South Korea Pulmonary Drugs Consumption (2017-2022)
8 Region and Country-wise Pulmonary Drugs Market Analysis and Outlook to 2028
-
8.1 Global Pulmonary Drugs Consumption Forecast (2022-2028)
-
8.2 United States Pulmonary Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Pulmonary Drugs Consumption Forecast (2022-2028)
-
8.4 China Pulmonary Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Pulmonary Drugs Consumption Forecast (2022-2028)
-
8.6 India Pulmonary Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Pulmonary Drugs Consumption Forecast (2022-2028)
9 Global Pulmonary Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Pulmonary Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Inhaled Corticosteroids Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Long Acting Beta-2 Agonists Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Antihistamines Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Vasodilators Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Pulmonary Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Others Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Others Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Global Pulmonary Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Pulmonary Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Inhaled Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Long Acting Beta-2 Agonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Antihistamines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Vasodilators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pulmonary Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Pulmonary Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pulmonary Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pulmonary Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pulmonary Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pulmonary Drugs Market Competitive Analysis
-
14.1 Cheisi Farmaceutici SpA
-
14.1.1 Cheisi Farmaceutici SpA Company Details
-
14.1.2 Cheisi Farmaceutici SpA Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Cheisi Farmaceutici SpA Pulmonary Drugs Product and Service
-
14.2 Meda Pharmaceuticals
-
14.2.1 Meda Pharmaceuticals Company Details
-
14.2.2 Meda Pharmaceuticals Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Meda Pharmaceuticals Pulmonary Drugs Product and Service
-
14.3 Mallinckrodt Pharmaceuticals Plc
-
14.3.1 Mallinckrodt Pharmaceuticals Plc Company Details
-
14.3.2 Mallinckrodt Pharmaceuticals Plc Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Mallinckrodt Pharmaceuticals Plc Pulmonary Drugs Product and Service
-
14.4 AstraZeneca Plc
-
14.4.1 AstraZeneca Plc Company Details
-
14.4.2 AstraZeneca Plc Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AstraZeneca Plc Pulmonary Drugs Product and Service
-
14.5 Merck Sharp & Dohme Limited
-
14.5.1 Merck Sharp & Dohme Limited Company Details
-
14.5.2 Merck Sharp & Dohme Limited Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merck Sharp & Dohme Limited Pulmonary Drugs Product and Service
-
14.6 Sanofi SA
-
14.6.1 Sanofi SA Company Details
-
14.6.2 Sanofi SA Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sanofi SA Pulmonary Drugs Product and Service
-
14.7 Zambon Company SpA
-
14.7.1 Zambon Company SpA Company Details
-
14.7.2 Zambon Company SpA Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Zambon Company SpA Pulmonary Drugs Product and Service
-
14.8 GlaxoSmithKline Plc
-
14.8.1 GlaxoSmithKline Plc Company Details
-
14.8.2 GlaxoSmithKline Plc Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 GlaxoSmithKline Plc Pulmonary Drugs Product and Service
-
14.9 Alaxia SAS
-
14.9.1 Alaxia SAS Company Details
-
14.9.2 Alaxia SAS Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Alaxia SAS Pulmonary Drugs Product and Service
-
14.10 Circassia Pharmaceuticals Plc
-
14.10.1 Circassia Pharmaceuticals Plc Company Details
-
14.10.2 Circassia Pharmaceuticals Plc Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Circassia Pharmaceuticals Plc Pulmonary Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pulmonary Drugs
-
Figure Pulmonary Drugs Picture
-
Table Global Pulmonary Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pulmonary Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pulmonary Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pulmonary Drugs Consumption by Country (2017-2022)
-
Figure United States Pulmonary Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Pulmonary Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Pulmonary Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Pulmonary Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Pulmonary Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pulmonary Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Pulmonary Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Pulmonary Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pulmonary Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pulmonary Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pulmonary Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pulmonary Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pulmonary Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inhaled Corticosteroids Consumption and Growth Rate (2017-2022)
-
Figure Global Long Acting Beta-2 Agonists Consumption and Growth Rate (2017-2022)
-
Figure Global Antihistamines Consumption and Growth Rate (2017-2022)
-
Figure Global Vasodilators Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Inhaled Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Long Acting Beta-2 Agonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antihistamines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vasodilators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pulmonary Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pulmonary Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Cheisi Farmaceutici SpA (Foundation Year, Company Profile and etc.)
-
Table Cheisi Farmaceutici SpA Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cheisi Farmaceutici SpA Pulmonary Drugs Product and Service
-
Table Meda Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Meda Pharmaceuticals Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Meda Pharmaceuticals Pulmonary Drugs Product and Service
-
Table Mallinckrodt Pharmaceuticals Plc (Foundation Year, Company Profile and etc.)
-
Table Mallinckrodt Pharmaceuticals Plc Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mallinckrodt Pharmaceuticals Plc Pulmonary Drugs Product and Service
-
Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Plc Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Plc Pulmonary Drugs Product and Service
-
Table Merck Sharp & Dohme Limited (Foundation Year, Company Profile and etc.)
-
Table Merck Sharp & Dohme Limited Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Sharp & Dohme Limited Pulmonary Drugs Product and Service
-
Table Sanofi SA (Foundation Year, Company Profile and etc.)
-
Table Sanofi SA Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA Pulmonary Drugs Product and Service
-
Table Zambon Company SpA (Foundation Year, Company Profile and etc.)
-
Table Zambon Company SpA Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zambon Company SpA Pulmonary Drugs Product and Service
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Pulmonary Drugs Product and Service
-
Table Alaxia SAS (Foundation Year, Company Profile and etc.)
-
Table Alaxia SAS Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alaxia SAS Pulmonary Drugs Product and Service
-
Table Circassia Pharmaceuticals Plc (Foundation Year, Company Profile and etc.)
-
Table Circassia Pharmaceuticals Plc Pulmonary Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Circassia Pharmaceuticals Plc Pulmonary Drugs Product and Service
-
